Therapeutic angiogenesis by controlled-release fibroblast growth factor in a patient with churg-strauss syndrome complicated by an intractable ischemic leg ulcer

American Journal of the Medical Sciences

Volumn 338, Issue 4, 2009, Pages 341-342

  Kawanaka, Hidekazu ^a   Takagi, Gen ^a   Miyamoto, Masaaki ^a   Tara, Shuhei ^a   Takagi, Ikuyo ^a   Takano, Hitoshi ^a   Yasutake, Masahiro ^a   Tabata, Yasuhiko ^b   Mizuno, Kyoichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Drug delivery system; Maggot debridement therapy; Protein therapy; Regenerative therapy; Vasculitis

Indexed keywords

RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR;

AGED; ANGIOGENESIS; ANKLE BRACHIAL INDEX; ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL ORGAN; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BIODEGRADABILITY; CASE REPORT; CHURG STRAUSS SYNDROME; CONTROLLED RELEASE FORMULATION; DEBRIDEMENT; DERMIS; DISEASE COURSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; HUMAN; HUMAN TISSUE; HYDROGEL; LEG ISCHEMIA; LEG MUSCLE; LEG ULCER; MAGGOT; MAGGOT THERAPY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OXYGEN TENSION; REGENERATION; SKIN AUTOGRAFT; SKIN ULCER; TREATMENT FAILURE; TREATMENT OUTCOME; ULCER HEALING; VASCULITIS; WOUND HEALING;

EID: 70350138470     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181abbd09     Document Type: Article

References (7)

1. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33: 1094-1100
2. Diri E, Buscemi DM, Nugent KM. Churg-Strauss syndrome: diagnostic difficulties and pathogenesis. Am J Med Sci 2003;325:101-105
3. Tabata Y, Miyao M, Yamamoto M, et al. Vascularization into a porous sponge by sustained release of basic fibroblast growth factor. J Biomater Sci Polym Ed 1999;10:957-968
4. Beasley WD, Hirst G. Making a meal of MRSA-the role of biosurgery in hospital-acquired infection. J Hosp Infect 2004;56:6-9.
5. Miyamoto M, Yasutake M, Takano H, et al. Therapeutic angiogenesis by autologous bone marrow cell implantation for refractory chronic peripheral arterial disease using assessment of neovascularization by 99mTc-tetrofosmin (TF) perfusion scintigraphy. Cell Transplant 2004; 13:429-437
6. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002;360:427-435
7. Takagi G, Miyamoto M, Yasutake M, et al. A novel therapy using control-released basic fibroblast growth factor in patients with peripheral artery disease: comparison with bone marrow mononuclear cell implantation [abstract]. Circulation 2006;114(suppl 2):446-447